Showing results (1331-1340 of 1,344) with videos related to

Sort By:
Pageof 135
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 2, 2025
Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: The Phase III MECCA TrialRuo-Xi Hong, Fei Xu, Wen Xia, et al.
In Vivo (Athens, Greece)|December 26, 2023
Spectrum of PHEX Mutations and FGF23 Profiles in a Taiwanese Cohort With X-Linked Hypophosphatemia Including 102 PatientsPen-Hua Su, Ju-Shan Yu, Yu-Zhen Wu, et al.
Emerging Microbes & Infections|March 20, 2023
Emergence of an ancient and pathogenic mammarenavirusXue-Lian Luo, Shan Lu, Chuan Qin, et al.
Pharmacological Research|June 1, 2021
Saponins isolated from Radix polygalae extent lifespan by modulating complement C3 and gut microbiotaWu Zeng, An Guo Wu, Xiao-Gang Zhou, et al.
Journal of Medical Virology|July 9, 2025
Dynamics of Crossed Acquired Immunity Against SARS-CoV-2 Variants: From Vaccine to Hybrid Immunity in ChinaHao Wang, Zhihao Zhang, Mengze Gan, et al.
Brain : a Journal of Neurology|November 11, 2025
Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre studyLing-Ling Li, Rong-Ze Wang, Zhen Wang, et al.
World Journal of Pediatrics : WJP|February 20, 2026
Management of pulmonary thromboembolism in children: an evidence-based expert consensusLi-Nan Zeng, Ying-Xue Zou, Hai-Lin Zhang, et al.
Circulation Research|March 29, 2017
Genome-Wide Analysis of DNA Methylation and Acute Coronary SyndromeJun Li, Xiaoyan Zhu, Kuai Yu, et al.
Cell Discovery|February 16, 2022
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2Yu Liang, Jing Zhang, Run Yu Yuan, et al.
JAMA|December 10, 2020
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical TrialXi Wang, Shu-Sen Wang, Heng Huang, et al.
Pageof 135